cyc 202 has been researched along with Ewing Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mateo-Lozano, S; Notario, V; Tirado, OM | 1 |
1 other study(ies) available for cyc 202 and Ewing Sarcoma
| Article | Year |
|---|---|
Roscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Enzyme Activation; Humans; Male; Mice; Mice, Nude; Purines; Roscovitine; Sarcoma, Ewing; Up-Regulation; Xenograft Model Antitumor Assays | 2005 |